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Abstract
Objectives: Insulin expression is highly controlled on the posttranscriptional level.
The RNA binding proteins (RBPs) responsible for this result are still largely
unknown.
Methods and results: To identify RBPs that bind to insulin mRNA we performed
mass spectrometry analysis on proteins that bound synthetic oligonucloetides
mimicing the 5′- and the 3′-untranslated regions (UTRs) of rat and human insulin
mRNA in vitro. We observed that the RBPs heterogeneous nuclear
ribonucleoprotein (hnRNP) U, polypyrimidine tract binding protein (PTB),
hnRNP L and T-cell restricted intracellular antigen 1-related protein (TIA-1-
related protein; TIAR) bind to insulin mRNA sequences, and that the in vitro
binding affinity of these RBPs changed when INS-1 cells were exposed to glucose,
3-isobutyl-1-methylxanthine (IBMX) or nitric oxide. High glucose exposure
resulted in a modest increase in PTB and TIAR binding to an insulin mRNA
sequence. The inducer of nitrosative stress DETAnonoate increased markedly
hnRNP U and TIAR mRNA binding. An increased PTB to TIAR binding ratio in
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vitro correlated with higher insulin mRNA levels and insulin biosynthesis rates in
INS-1 cells. To further investigate the importance of RNA-binding proteins for
insulin mRNA stability, we decreased INS-1 and EndoC-βH1 cell levels of PTB
and TIAR by RNAi. In both cell lines, decreased levels of PTB resulted in lowered
insulin mRNA levels while decreased levels of TIAR resulted in increased insulin
mRNA levels. Thapsigargin-induced stress granule formation was associated with
a redistribution of TIAR from the cytosol to stress granules.
Conclusions: These experiments indicate that alterations in insulin mRNA
stability and translation correlate with differential RBP binding. We propose that
the balance between PTB on one hand and TIAR on the other participates in the
control of insulin mRNA stability and utilization for insulin biosynthesis.
Keywords: Biological sciences, Cell biology
1. Introduction
Type 2 diabetes is characterized by a relative lack of insulin [1, 2], which may in
part be due to an insufficient biosynthesis of the hormone [3]. The amount of
insulin synthesized in beta-cells depends on the levels of translatable insulin
mRNA and how efficiently the messenger is used for insulin biosynthesis. Due to
the high copy number of insulin mRNA in insulin producing cells, alterations in
insulin mRNA levels result to a large extent from changes in messenger stability,
rather than transcriptional mechanisms [4]. Post-transcriptional control of mRNA
stability is primary carried out by RNA binding proteins (RBPs) [5]. RBPs perform
a wide array of functions that determine the splicing, stability, localization and
translation of the transcripts [6]. Previous work on insulin mRNA has shown that
both the 5′- and the 3′-untranslated regions (UTRs) of insulin mRNA are important
for glucose-induced insulin biosynthesis, and that the 3′-UTR is especially
important for insulin mRNA stability [4, 7, 8]. The polypyrimidine tract binding
protein (PTB) is a RNA binding protein that has been shown to participate in pre-
mRNA splicing [9], poly-adenylation [10], mRNA transport [11], IRES-mediated
translation [12] and mRNA stabilization [13]. In insulin producing beta-cells PTB
is known to stabilize the insulin mRNA by binding to a conserved pyrimidine rich
sequence within the 3′-UTR insulin mRNA [4]. PTB also binds to the 5'-UTR of
the human insulin mRNA which we and others have previously linked to cap-
independent translation of insulin [14, 15]. Interestingly, PTB also stabilizes other
proteins involved in the secretory pathway of insulin [16]. This supports the idea
that specific RBPs can interact with distinct subsets of mRNAs to coordinate gene
expression patterns in response to environmental and cellular conditions [17]. In
other cell systems, PTB is known to exert its functions on mRNA stability and
translation in cooperation with other RNA-binding proteins [18]. This is in line
with the notion that the diverse and complex functions performed by the RBP
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requires the activities of multiprotein complexes. Thus, it can be hypothesized that
PTB together with other proteins are involved in the regulation of insulin mRNA.
The aim of our work was therefore to identify putative RBPs that bind to insulin
mRNA and possibly participate in the control of insulin mRNA stability and
translation. We demonstrate that a glucose-induced increase in the affinity of PTB
and TIAR to the insulin mRNA UTR regions correlated with increased insulin
biosynthesis rates. In contrast, a nitric oxide-induced increase in the affinity of
hnRNP U and TIAR correlated with decreased insulin biosynthesis. In addition,
down-regulation of PTB levels decreased insulin mRNA levels whereas down-
regulation of TIAR levels resulted in the opposite. Taken together these
experiments indicate that the beta cell utilizes several RNA binding proteins to
regulate the stability and translation of insulin mRNA.
2. Materials and methods
2.1. Cell culture
The rat insulinoma cell line INS-1 832/13 was cultured in RPMI 1640 and
maintained in a humidified air + 5% CO2 incubator at 37 °C. The media used for
INS-1 832/13 cells was supplemented with 10% fetal calf serum, 10 mM HEPES,
2 mM L-glutamine, 1 mM sodium pyruvate, 50 μM β-mercaptoethanol and
antibiotics. Human EndoC-βH1, a kind gift from Profs. R. Scharfmann and P.
Ravassard, INSERM, Paris, France, cells were cultured in extracellular matrix/
fibronectin-coated plates in 5.5 mM glucose Dulbecco’s Modified Eagle medium
(DMEM) with supplements as previously described [19].
2.2. Human islets
Isolated human islets were provided by Professor Olle Korsgren (the Department
of Radiology, Oncology and Clinical Immunology at Uppsala University Hospital,
Uppsala, Sweden) through the Uppsala facility for the isolation of human islets
from Scandinavian brain-dead individuals, and through the JDRF award
31-2008-416 (ECIT Islet for Basic Research program). The islets were precultured
for 3–7 days in CMRL 1066 (ICN Biomedicals, Costa Mesa, CA, USA)
supplemented with 10 mM HEPES, 2 mM L-glutamine, 50 μg/mL gentamycin,
0.25 μg/mL fungizone (GIBCO, BRL), 20 μg/mL ciproxfloxacin (Bayer healthcare
AG, Leverkusen, Germany) and 10 mM nicotinamide. The islet beta-cell
percentage was determined using Newport green staining followed by fluorescence
microscopy and beta-cell percentages were routinely 30–60%.
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2.3. Treatments
The cells were incubated for 3 h either in 1.67 mM glucose (LG), 11.1 mM glucose
(control) 16.7 mM glucose (HG), 11.1 mM glucose + 1 mM IBMX or 11.1 mM
glucose + 1 mM DETAnonoate.
2.4. Preparation of cytoplasmic extract
After incubation the INS-1 cells/human islets were washed in cold phosphate
buffered saline and resuspended in solution A, a 10 mM HEPES buffer (pH 7.9)
supplemented with 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and proteinase and
phosphatase inhibitor cocktail (Thermo Scientific). The cells were incubated on ice
for 10 min and following a brief centrifugation and again resuspended in solution
A before they were lysed with an electric homogenizer. The lysates were then
centrifuged for 5 min at 800 x g at 4° C, after which the supernatants were
collected. At this point 40 μl of the cytoplasmic extract was saved as total lysate
control.
2.5. RNA-oligonucleotide affinity binding
Streptavidin coated Dynabeads were washed in the recommended washing and
binding (B/W) buffer. The beads were then divided into separate Eppendorf tubes
(300 mg/group) and 1 nmol of biotin labeled RNA oligonucleotide was added. The
oligonucleotides used were:
Rat
5′ short: 5′-Biotin-ACCAUCAGCAAGCAGGUCAUUGUUCCAAC-3′
5’long:5′-GCUACAAUCAUAGACCAUCAGCAAGCAGGUCAUUGUUC-
CAACAUGGCCCU-Biotin-3′
3′ short: 5′-Biotin-UCCACCACUCCCCGCCCACCCCUCU −3′
3 ’ l ong :5 ′-B io t in - CCACCACUCCCCGCCCACCCCUCUGCAAU-
GAAUAAAGCCUUUGAAUGAGC-3′
Human
5′ short: 5′-Biotin-GGCCAUCCAGCAGAUCACUGUCCUUCUGCC-3′
5’long:5′-Biotin-AGAGGCCAUCAAGCAGAUCACUGUCCUUCUGC-
CAUGGCCCU-3′
3′ short 1: 5′-Biotin-CGCAGCCCCCCACCCGCCGCCUCCU-3′
3′ short 2: 5′-AGGUGGGGCAGGUGGAGCUG-3′
For control, a scrambled non-specific oligonucleotide was used:
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Ctrl: 5′-Biotin-GCGAGGAUACGAUAGGCGCAUACAGAAGUA-3′
The tubes were slowly rotated for 30 min at 4° C. After binding of the
oligonucleotides the beads were again washed in W/B buffer and resuspended in
400 μl of the cytoplasmic extract. The incubation took place for 60 min at 4° C in
the presence of RNAguard. After incubation the beads were washed three times in
solution A and resuspended in 1x SDS-sample buffer. To elute the proteins the
beads were boiled for 5 min in the SDS-sample buffer.
2.6. 1-D PAGE and digestion
Eluted proteins were separated using 9% one-dimensional SDS-PAGE gels. The
gels were fixated in 40% (v/v) ethanol and 10% (v/v) acetic acid, after which the
protein bands were visualized using colloidal Coomassie staining. The protein
bands specific to the sample lane (i.e. not present in control lane) were excised and
samples were in-gel reduced, alkylated, and digested with modified sequence-
grade trypsin (Promega, Madison, WI) as previously described [20]. Samples were
vacuum-centrifuged and reconstituted prior to analysis in 12 μl of HPLC water
containing 0.1% TFA (Sigma).
2.7. Nanoflow LC/MS/MS
All experiments were performed on a 7-Tesla hybrid lin0ear ion trap Fourier
transform mass spectrometer (LTQ FT, Thermo Electron, Bremen, Germany) using
a modified nanoelectro-spray ion source (Proxeon Biosystems, Odense, Denmark).
The HPLC setup consisted of a solvent degasser, nanoflow pump, and thermostated
microautosampler (Agilent 1100 nanoflow system). A 15-cm fused silica emitter
(75-μm inner diameter, 375-μm outer diameter; Proxeon Biosystems) was used as
analytical column. The emitter was packed in-house with a methanol slurry of
reverse-phase, fully end-capped Reprosil-Pur C18-AQ 3-μm resin (Dr. Maisch
GmbH, Ammerbuch-Entringen, Germany) using a pressurized “packing bomb”
operated at 50–60 bars (Proxeon Biosystems). Mobile phases consisted of 0.5%
acetic acid and 99.5% water (v/v) (buffer A) and 0.5% acetic acid and 10% water in
89.5% acetonitrile (v/v) (buffer B). 8 μl of prepared peptide mixture was
automatically loaded onto the column over 20 minutes at 5% buffer B, flow rate of
500 nl/min followed by a 90-min gradient from 5 to 45% buffer B at a constant
flow rate of 200 nl/min. MS analysis was performed in data-dependent acquisition
(DDA) mode in which the mass spectrometer automatically switches between a
high resolution survey scan (resolution @ = 100,000; m/z range, 200–1600). The
precursor scan was followed by MSMS fragmentation using the complementary
techniques of ECD and CAD [20, 21] on the two most intense precursor ions
identified in the MS1 scan event.
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2.8. Peptide and modification identification
Acquired RAW files were converted to dta files using Extract msn through
BioWorks Browser (Thermo Electron), and complementary pairs were identified as
previously described [22]. Peptides were identified by searching against the NCBI
(National Center for Biotechnology Information) database using the Mascot search
engine. Searches were performed permitting 2 trypsin miscleavages and the mass
tolerance for monoisotopic peptide identification was set to 10 ppm and ±0.02 Da
for fragment ions. The instrument setting was “ESI-FTICR”. The peptide mass
tolerance, mass accuracy window for fragment ions, and enzyme specificity as well
as the instrument settings were kept unchanged. Parsing of data and statistical
analysis of the search results reported by Mascot were performed using the open-
source software MSQuant [21].
2.9. SDS-PAGE and immunoblotting
Protein samples in SDS-sample buffer were separated on SDS-PAGE. Proteins
were electrophoretically transferred to Hybond-P filters (Amersham Biosciences),
which were then blocked for one hour using a 5% bovine serum albumin (BSA)
protein solution. The filters were probed with primary antibodies for PTB, hnRNP
L, hnRNP U, TIAR and ERK. The horseradish peroxidase conjugated anti-mouse,
anti-rabbit or anti-goat antibodies were used as secondary antibodies and the
immunodetection was performed as described for the ECL immunoblotting
detection system by Amersham Biosciences, using the Kodak Image station
4000MM. The resulting bands were quantified using Kodak Digital Science ID
software.
2.10. siRNA transfection
For siRNA transfection of INS-1 cells, we used 60 nM of a pre-designed siRNA
oligonucleotide directed against PTB with the antisense sequence 5′-AUUUACA-
CUCUUCCAUGACtt-3′ (Dharmacon). The siRNA against TIAR was also
purchased from Dharmacon (LOC361655 siGENOME SMARTpool). To introduce
the siRNAs into the cells we used Lipofectamine (Invitrogen) according to the
manufacturer’s recommendation. The control consisted of 60 nM of non-targeting
siRNA (Dharmacon). The transfection took place for 3 h after which the cells were
cultured for 24, 48 or 72 h in complete culture medium. All experiments were run
in duplicate and after harvest the cells were either used for semi-quantitative real-
time PCR or Western blot. For siRNA transfection of EndoC-βH1 cells
Dharmafect I (Dharmacon) was used according to the instructions of the
manufacturer. Human smartpool siGENOME siRNA sequences directed against
PTB and TIAR, and used at 60 nM, were from Dharmacon.
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2.11. Total RNA isolation and cDNA synthesis
Cells were washed once with phosphate-buffered saline and 200 μl of UltraSpec
RNA Isolation Solution (BioTecx Laboratories) was added to each sample. Total
RNA was extracted according to the instructions of the manufacturer.
The cDNA synthesis was performed using iScript Reverse Transcription Supermix
for RT-qPCR (Bio Rad). The synthesis reaction was terminated by heating at 95 °C
for 5 min after which the samples were stored at −20 °C. Before the cDNA
samples were analyzed by real-time PCR, they were purified using the Viogene
PCR-M Cleanup System. All steps were performed according to manufacturers
recommendations.
2.12. Semi-quantitative real time PCR
The real time PCR was performed on a Light Cycler II instrument (Roche) using
the SYBR Green Taq Readymix (Roche). This value was then normalized against
the value for β-actin, GAPDH and G6PDH. Primer sequences are available upon
request.
2.13. Insulin and total protein biosynthesis
INS-1 cells were incubated for 3 h in 200 μl sterile Krebs-Ringer bicarbonate
buffer supplemented with 10 mM HEPES (Sigma) (KRBH), 2 mg/ml BSA and
50 μCi/ml L-[3,4,5-3H] leucine (GE Healthcare Life Science, Chalfont St. Giles,
Buckinghamshire, UK). After incubation, and incorporation of radioactive leucine,
the cells were washed once in PBS, harvested using a rubber policeman and
homogenized by sonication (22 kHz, 50 W) for 10 s in 200 μl of a 50 mM glycine
buffer (pH 8.8) supplemented with 2.5 mg/ml BSA. For insulin analysis, four 10 μl
aliquots of each sample were transferred to Ellerman tubes and mixed with 100 μl
50 mM glycine buffer (pH 8.8) supplemented with 2.5 mg/ml BSA and 0.1%
Triton X–100, and in duplicates supplied with 10 μl of guinea pig anti-human
insulin serum (Chemicon International, Temecula, CA, USA) or 10 μl normal
guinea pig serum (Harlan Sera-lab, loughborough, Leicestershire, UK). The tubes
were mixed and incubated for 1 h in room temperature. 100 μl protein A-Sepharose
(Amersham-Pharmacia Biotech, Uppsala, Sweden) were added and the tubes
tumbled at room temperature for 15 min and then centrifuged for 1 min at 200 x g.
The Sepharose beads were washed twice in 500 μl buffer and subsequently
resuspended in 500 μl 1 M acetic acid with 2.5 mg/ml BSA.
For total protein analysis, two 10 μl aliquots of each sample were transferred to
Ellerman tubes, to which 250 μl 50 mM glycine buffer (pH 8.8) supplemented with
2.5 mg/ml BSA and 250 μl of 10% trichloroacetic acid were added. The tubes were
vortexed and then centrifuged for 2 min at 14000 x g. After removal of the
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supernatant the precipitate was dissolved in 500 μl 0.15 M NaOH. To determine
the radioactivity, the samples were transferred to scintillation vials together with 4
ml Ultima Gold scintillation fluid and analyzed with liquid scintillation
spectrometry (Wallac System 1409) using external standardization.
2.14. Immunofluorescence
INS-1 832/13 ells were cultured overnight on poly-L-lysine treated coverslips and
treated with thapsigargin (200 nM) for different time periods. Cells were then
fixated in 4% paraformaldehyde for 10 min, permeabilized for 10 min in PBS + 2%
BSA and 0.5% Triton X–100, and then and blocked for 1 h in PBS + 2% BSA.
Samples were incubated with TIAR or Dcp1A (dilution respectively 1:100 and
1:200, Santa Cruz Biotechnology) antibodies for 1 h at room temperature.
Secondary anti- goat or anti-mouse antibodies (dilution respectively 1/1000 and
1:500; Santa Cruz Biotechnology) were then applied for 1 h at room temperature in
the dark.
2.15. Fluorescence microscopy
All images were acquired a Nikon Eclipse TE2000-E laser-scanning confocal
microscope using the x60 objective lens. The fluorescence was excited with 488
nm for the green fluorescence and 594 nm for red fluorescence. DAPI staining was
used for visualization of cell nuclei.
3. Results
3.1. Identification of proteins that bind to the 3′-UTR of insulin
mRNA in vitro
To our knowledge, PTB, human antigen D (HuD) and protein-disulfate isomerase
are the only RBPs known to associate with insulin mRNA UTR-sequences [4, 23,
24]. To identify other proteins that participate in the control of insulin mRNA
stability and translation, a biotinylated RNA oligonucleotide corresponding to
nucleotides 392–417 of rat insulin I mRNA was incubated with cytoplasmic
extracts from INS-1 cells. As control for unspecific binding we used a scrambled
oligonucleotide with the same nucleotide composition. The Dynabead purified
proteins were separated on polyacrylamide gels and stained with Coomassie blue
(Fig. 1). Bands specific for the insulin mRNA sequence (indicated by arrows) were
excised, in-gel digested and analyzed by ultra-high resolution mass spectrometry.
The subsequent analysis identified a number of proteins (Fig. 1), including, but not
limited to: hnRNP U, hnRNP K, hnRNP L, PTB, polyC-binding protein (PCBP) 1,
2, 3 and TIAR. The mass spectrometry results were confirmed by immunoblotting
using commercially available antibodies against PTB, hnRNP U, hnRNP L and
TIAR, and these RBPs were chosen for further investigation. HnRNP U is an 120
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kDa RNA/DNA-binding protein that has many functions, for example transcrip-
tional regulation [25], nuclear matrix/scaffold attachment [26] and RNA
processing [27]. HnRNP L is a splicing factor that in addition to controlling
alternative splicing [28] also influences translation [29] and polyA shortening [30].
TIAR is an RNA binding protein that primarily promotes translational arrest and
relocalization of mRNAs to p-bodies and stress granules [31], but also apoptosis
[32].
3.2. In vitro affinity of PTB, hnRNP U, hnRNP L and TIAR to
sequences within the 3′- and 5′-UTRs of insulin mRNA
Both the 3′-UTR and the 5′-UTR of the insulin mRNA are important for control of
stability and translation [7]. To further elucidate which parts of the 3′- and 5′-
UTRs to which different RBPs bind, we designed 5′- and 3′-UTR sequences that
consisted only of the core pyrimidine rich sequence, or UTR-sequences which
contained both the pyrimidine rich sequence and the surrounding non-pyrimidine
rich sequences (Fig. 2A). In addition, based on a predicted secondary structure
(mfold, version 3.5) in which the two insulin mRNA UTRs interact with each other
(Fig. 2B), we constructed a sequence consisting of both a long 3′- and a long 5′-
UTR, so that intramolecular 5′ to 3′ binding and interaction achieved. The rationale
for this is that RBPs may differentiate between single and double stranded mRNA
structures upon binding in vivo. The different RNA oligonucleotides were allowed
to incubate with INS-1 cell extracts and RBP binding was assessed by immunoblot
analysis (Fig. 3). The results show that hnRNP U bound to all RNA
[(Fig._1)TD$FIG]
Fig. 1. Identification of proteins that bind to the 3′-UTR of insulin mRNA in vitro by mass
spectrometry. Cytoplasmic extracts from human islets and INS-1 cells were incubated with streptavidin
coated Dynabeads carrying a scrambled RNA oligonucleotide (Ctrl) or an RNA oligonucleotide
corresponding to the pyrimidine rich sequence of the insulin 3′-UTR (denoted as 3′ short in Fig. 2).
Bound proteins were eluted and separated on polyacrylamide gels that were subsequently fixed and
stained with coomassie blue. Specific bands were excised and the proteins identified by Fourier
Transform Mass Spectrometry. Identified proteins are shown next to their corresponding bands.
Proteins in bold were chosen for further investigation.
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oligonucleotides except the short 3′-UTR. This suggests that in the case of hnRNP
U, some other protein, possibly PTB, blocks the binding to the short pyrimidine
rich 3′-UTR oligonucleotide. hnRNP L bound all oligonucleotides, including the
scrambled control, with the same affinity, indicating sequence non-specific
binding. Interestingly, hnRNP L binding to the short 3′-UTR was not blocked by
PTB. Furthermore, PTB binding was very strong to both 3′-UTR oligonucleotides
and weaker to the two 5′-UTR oligonucleotides. The weak binding to the 5′-UTR
may be explained by the lower content of pyrimidines of the 5′-UTR of rat insulin
mRNA as compared to that of the 3′-UTR and the 5′-UTR of human insulin
mRNA (Fig. 2A). TIAR bound all insulin mRNA oligonucleotides with similar
affinity. The finding that TIAR binding to the short 3′-UTR was not blocked by
PTB indicates that the two RBPs do not compete for the same binding site, unlike
PTB and hnRNP U. RBP binding to the combination of the long 5′-UTR and the
long 3′-UTR was similar to that of only the 3′-UTR.
The binding of PTB in human islet extracts to RNA oligonucleotides with
sequences from human 3′- and 5′-UTR of insulin mRNA (Fig. 2A) was also
studied. Due to limited availability of human islet material and low signal
intensities in immunoblot analysis, we could not study hnRNP L, hnRNP U and
TIAR binding in human samples. To see whether PTB prefers dsRNA or ssRNA,
[(Fig._2)TD$FIG]
Fig. 2. RNA oligonucleotides corresponding to specific 3′- and 5′-UTR sequences of the human and rat
I insulin mRNA. In (A), the different RNA-oligonucleotides used in the Dynabead pull down
experiments are shown. Oligonucleotides representing different regions of the human and rat 3′- and 5′-
UTRs were biotinylated so that RNA binding proteins could be affinity purified using streptavidin
coated dynabeads. Boxes represent pyrimidine rich sequences with potentially regulatory roles for
mRNA stability and translation. The numbering of the first and last nucleotides corresponds to their
position on the mRNA according to their NCBI accession number, NM_000207.2 and NM_019129.3
respectively. In (B), a simplified representation of the predicted interaction between the two long rat
oligonucleotides is shown.
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Fig. 3. In vitro affinity of RNA binding proteins to oligonucleotides corresponding to specific 3′- and
5′-UTR sequences of rat (A) and human (B) insulin mRNA. RNA binding proteins from INS-1 cells
were affinity purified using Dynabeads, separated by SDS-PAGE and analyzed by immunoblotting. The
oligonucleotides used were those described in Fig. 2 and in one group (3′ + 5′ long) both the 3′ long and
the 5′ long oligonucleotides were loaded on the beads so that complexes between the two
oligonucleotides could be formed (Fig. 2B). In (A), protein bands for hnRNP U and hnRNP L were
normalized against the signal from a scrambled control oligonucleotide (scr) while PTB and TIAR were
normalized against the signal from the short oligonucleotide corresponding to the 3′-UTR of the rat
insulin mRNA. The lower panel in A shows a representative blot with all four proteins. In (B), the PTB
signal from a corresponding experiment using human islets is shown. Instead of a longer 3′-UTR
oligonucleotide a non-biotinylated complementary oligonucleotide was used to mimic double stranded
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we used a RNA-oligonucleotide with two short antiparallel 3′-UTR oligonucleo-
tides forming a dsRNA molecule. In two independent experiments we observed
that human PTB binds with high affinity, not only to the 3′-UTR of insulin mRNA,
but also to the 5′-UTR (Fig. 3B). The binding to the long and the short 5′-UTR
oligonucleotides may occur via the pyrimidine rich region of the short 5′-UTR
oligonucleotide. The binding of PTB to single stranded and double stranded 3′-
UTR was comparable (Fig. 3B). Taken together these results suggest that PTB
binds to the pyrimidine rich sequences of both the 3′- and the 5′-UTR in human
insulin mRNA and that PTB and hnRNP U compete for binding to the same
pyrimidine rich sequence of the rat insulin mRNA 3′-UTR. HnRNP L and TIAR
both bind the 3′- and 5′-UTRs at sites different from those for PTB. Finally, RBP
binding patterns are not affected by double stranded RNA structures.
3.3. Effects of high glucose, IBMX and DETAnonoate on RBP
binding to insulin mRNA 3′- and 5′-UTR oligonucleotides
It is possible that external factors modulate insulin production by altering RBP
binding to insulin mRNA. Glucose is a well-known stimulator of insulin mRNA
stability and translation [33, 34]. The cAMP raising compound IBMX has been
reported to promote PTB translocation from the nucleus to the cytosol, thereby
stimulating insulin production [16]. DETAnonoate promotes nitrosative stress and
decreased insulin production [35]. To investigate whether the affinities of the
aforementioned RBPs to insulin mRNA 3′- and 5′-UTRs are affected by treatments
that both stimulate and decrease insulin production, the long 3′- and 5′-UTR
oligonucleotides were incubated with protein extracts from INS-1 cells incubated
for 180 min with 20 mM glucose, 1 mM IBMX or 1 mM DETAnonoate. We
normalized the RNA binding of PTB, hnRNP U and TIAR to that of hnRNP L, as
hnRNP L binding was non-specific (Fig. 3) and unaltered by the different
treatments (data not shown). The results show that the binding of PTB to the 3′ +
5′-UTRs was modestly increased in response to high glucose (Fig. 4). This finding
is consistent with previous studies indicating a stabilizing role of PTB for insulin
mRNA [4]. IBMX or DETAnonoate did not affect PTB binding activity. HnRNP U
binding was not modulated by high glucose or IBMX, but clearly stimulated by
DETAnonoate. Both high glucose and DETAnonoate promoted increased binding
of TIAR to the insulin mRNA UTRs. Thus, high glucose promoted a modest
increase in PTB and TIAR insulin mRNA binding, whereas nitrosative stress
stimulated markedly hnRNP U and TIAR binding.
RNA. The blot is representative for two experiments. Results in A are means ± SEM for 4 independent
experiments and * denotes p < 0.05 using Student’s paired t-test when comparing vs. corresponding
control. Full images can be found in Supplemental Fig. 3.
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[(Fig._4)TD$FIG]
Fig. 4. Effects of high glucose, IBMX and DETAnonoate on the affinity of RNA binding proteins to
oligonucleotides representing specific 3′- and 5′-UTR sequences of insulin mRNA in INS-1 cells. INS-
1 cells were cultured in RPMI 1640 medium with 1.67 mM glucose (control; C), 16.7 mM glucose (high
glucose; HG), 1 mM IBMX and 1 mM DETAnonoate (DNO) for 2 h. Cytoplasmix extracts from the
cells were incubated with beads carrying both the long 3′- and the long 5′-UTR oligonucleotides, and
the eluted proteins were analyzed by SDS-PAGE and immunoblotting. The affinity of hnRNP U, PTB
and TIAR was first normalized against hnRNP L, and then normalized against the control. The lower
panel in A shows a representative blot with all four proteins. The image is acquired after blotting for
hnRNP U, hnRNP L, PTB and TIAR in sequence, thus showing the correlation from a single
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3.4. Effects of glucose, IBMX and DETAnonoate on insulin
mRNA levels and insulin and total protein biosynthesis rates in
INS-1 cells
To correlate the insulin mRNA binding results to changes in the levels of insulin
mRNA and the translation of the insulin mRNA we treated the INS-1 cells as
above and performed semi-quantitative real-time RT-PCR and insulin and total
protein biosynthesis determinations. The results show that incubation in the
presence of a high glucose concentration for 3 h augmented insulin mRNA levels
as compared to a low glucose concentration (Fig. 5A). Insulin mRNA levels were
decreased by IBMX and DETAnonoate (Fig. 5A). Also insulin biosynthesis rates
were increased by high glucose as compared to the low glucose group (Fig. 5B).
Compared to the 11.1 mM glucose control group both IBMX and DETAnonoate
down-regulated insulin biosynthesis (Fig. 5B). The total protein biosynthesis,
however, was only decreased by the DETAnonoate treatment (Fig. 5C). These
observations indicate that a moderate increase in PTB and TIAR binding to insulin
mRNA, promoted by high glucose, is associated with enhanced insulin production,
whereas enhanced TIAR and hnRNP U binding, stimulated by nitrosative stress, is
associated with decreased insulin production.
3.5. Downregulation of PTB and TIAR in INS-1 and EndoC-
βH1 cells leads to lower and higher insulin mRNA levels,
respectively
To further substantiate the notion that PTB and TIAR control insulin mRNA
stability in opposite directions we down-regulated the two RBPs by siRNA
treatment. INS-1 cells were transfected using Lipofectamine and the cells were
incubated for 48 or 72 h after which they were harvested for immunoblot analysis
and semi-quantiative real-time PCR. The results show that PTB was significantly
decreased after 48 h of incubation (Fig. 6A) and that TIAR was downregulated
after 72 h (Fig. 6C). These effects were paralleled by increased and decreased
insulin mRNA levels, respectively (Fig. 6B, D). Also in the human EndoC-βH1
cells did downregulation of PTB and TIAR (Fig. 7A) result in decreased and
increased insulin mRNA levels, respectively (Fig. 7B). Thus, the stability of
insulin mRNA seems to be oppositely regulated by PTB and TIAR levels.
experiment. The lower panel shows representative blots for all four proteins. Results are means ± SEM
for 3–4 independent experiments and * denotes p < 0.05 using Student’s t-test when comparing vs.
corresponding control. Full images can be found in Supplemental Fig. 4.
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[(Fig._5)TD$FIG]
Fig. 5. The effects of glucose, IBMX and DETAnonoate on insulin mRNA levels (A) and insulin (B)
and total protein (C) biosynthesis in INS-1 cells. (A) INS-1 cells were cultured for 3 h in RPMI 1640
medium with 1.67 mM glucose (LG), 16.7 mM glucose (HG), 11.1 mM glucose (C), 11.1 mM glucose
and 1 mM IBMX (IBMX) or 11.1 mM glucose and 1 mM DETAnonoate (DNO) and were analyzed
using real time PCR. Insulin mRNA was normalized against GAPDH and expressed as percent of
control. Bars are means ± SD for 9 observations. * denotes p < 0.05 using Student’s t-test when
comparing HG to LG and IBMX and DNO to C. (B) INS-1 cells were labeled with 3H-leucine for three
h in a KRBH buffer containing BSA and 1.67 mM glucose (LG), 16.7 mM glucose (HG), 11.1 mM
glucose (C), 11.1 mM glucose and 1 mM IBMX (IBMX) or 11.1 mM glucose and 1 mM DETAnonoate
(DNO). Insulin was immunoprecipitated with guinea pig anti-insulin antibodies and protein A
sepharose, and total proteins were precipitated with TCA. Incorporated radioactivity was quantified by
liquid scintillation counting. Results are means ± SEM for 3 observations. * denotes p < 0.05 using
Student’s t-test when comparing HG to LG and IBMX and DNO to C.
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[(Fig._6)TD$FIG]
Fig. 6. Downregulation of PTB or TIAR leads to lower and higher insulin mRNA levels in INS-1 cells,
respectively. INS-1 cells were transfected with either control siRNA or siRNA against PTB for 3 h
using Lipofectamine according to the manufacturers recommendation. The cells where harvested after
48 h and (A) analyzed for PTB and ERK using immunoblot analysis. PTB-bands are normalized against
ERK and expressed as percent of the control. A representative blot is shown in the upper panel. In (B),
INS-1 cells treated as in A were analyzed using real time PCR. Insulin mRNA was normalized against
beta actin and expressed as percent of control. Bars are means ± SEM for 3 observations. *Denotes p <
0.05 compared to the control, using Student’s paired t-test. INS-1 cells were also transfected with either
control siRNA or siRNA against TIAR. The cells were harvested after 72 h and (C) analyzed for TIAR
using immunoblot analysis. TIAR-bands are normalized against ERK and expressed as percent of the
control. A representative blot is shown in the upper panel. In (D), INS-1 cells treated as in A were
analyzed using real time PCR. Insulin mRNA was normalized against G6PDH and expressed as percent
of control. Bars are means ± SEM for 3 or 4 observations. *Denotes p < 0.05 compared to the control,
using Student’s paired t-test. Full images can be found in Supplemental Fig. 6.
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3.6. Thapsigargin promotes formation of TIAR-containing stress
granules
Thapsigargin is a known inducer of ER stress, and in beta-cells it leads to stress
granule formation and decreased insulin mRNA levels [36]. As TIAR is known to
accumulate in stress granules and P-bodies [37], and to further substantiate that
TIAR binding to insulin mRNA signals decreased insulin biosynthesis, we exposed
INS-1 cells to thapsigargin for different time periods and analyzed stress granule
formation using a TIAR antibody. As expected thapsigargin induced a pronounced
and rapid increase of eIF2-alpha phosphorylation (Fig. 8A). This was paralleled by
[(Fig._7)TD$FIG]
Fig. 7. Downregulation of PTB and TIAR affects insulin mRNA levels in EndoC-βH1 cells. EndoC-
βH1 cells were transfected with either control siRNA or siRNA against PTB for 3 h using Dharmafect I
according to the manufacturers recommendation. The cells where harvested after either 72 h and (A)
analyzed for PTB and TIAR using immunoblot analysis. PTB- and TIAR-bands are normalized against
tubulin and expressed relative to the control. In (B), EndoC-βH1 cells were treated as in A and analyzed
using real-time PCR. Insulin mRNA was normalized against GAPDH and expressed relative to control.
Bars are means ± SEM for 5–8 observations. * denotes p < 0.05 and ** denotes p < 0.01 compared to
the control, using Student’s paired t-test.
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the appearance of distinct, cytoplasmic stress granules, as indicated by TIAR-
immunofluorescence (Fig. 8B). Thus, at conditions of ER stress, when the
biosynthesis of insulin is decreased [36], TIAR redistributes from being
homogenously distributed throughout the cytosol, to distinct stress granule foci.
As for Dcp1a, which is a P-body marker [38], its localization appears to be in the
periphery of the cells. Already at basal conditions Dcp1A is aggregated in small
cytosolic foci. Thapsigargin did not increase the number of P-bodies, but the
[(Fig._8)TD$FIG]
Fig. 8. Thapsigargin promotes formation of TIAR-containing stress granules in INS-1 cells. (A)
Thapsigargin induced eIF2-alpha phosphorylation in INS-1 cells. Full images can be found in
Supplemental Fig. 8A. (B) Immunofluorescence detection of the stress granule marker TIAR (green)
and the P-body marker Dcp1A (red) in INS-1 cells after thapsigargin treatment (200 nM) for different
time periods. Nuclei are visualized by DAPI (blue). Results are representative for 3 independent
experiments.
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Dcp1A intensity in P-bodies appeared stronger after thapsigargin exposure
(Fig. 8B). Some P-bodies co-localized with stress granules (Fig. 8B, arrows).
4. Discussion
The rat insulin mRNA 5′- and 3′-UTRs are short, only 59 and 77 nucleotides,
respectively. Yet they contain cis-elements that confer sophisticated control of
messenger stability, localization and translation. Glucose augments the biosynthe-
sis of insulin up to 10-fold [39] and insulin mRNA stability 2–3 fold [33]. These
events are known to require specific sequences localized to the UTR regions [7].
Here we report that in addition to PTB, both hnRNP U and TIAR bind in vitro to
sequences within the insulin mRNA UTRs, and that their affinity for these
sequences at different conditions correlates with changes in insulin mRNA levels.
More precisely, high glucose induced a modest increase in PTB and TIAR binding
to the two insulin mRNA UTRs in vitro, which was paralleled by an enhanced
insulin mRNA content. Also, down-regulation of PTB resulted in lower insulin
mRNA levels. Due to the long half-life of insulin mRNA (27–72 h, [33]), we have
not been able to directly quantify its stability. However, insulin mRNA is a highly
abundant molecule in beta-cells [4], and it is therefore unlikely that changes in
insulin mRNA levels during short-term incubations (3 h) reflect alterations in
transcriptional rates. Thus, the presently observed glucose-induced increase in
insulin mRNA most likely resulted from PTB-induced mRNA stabilization. This is
in line with previous studies demonstrating that PTB stabilizes insulin mRNA by
binding to its 3′-UTR [4, 16]. Interestingly, PTB enhances not only the stability of
insulin mRNA, but also that of other mRNAs such as the messengers for CD154
[40], VEGF [41], NO synthase [42], Rab8A and B-cpx I [43].
It is not clear how a high glucose concentration promotes PTB binding to insulin
mRNA. In our experiments IBMX did not increase PTB binding to the 3′- and 5′-
UTR oligonucleotides, which does not give support to a role for cAMP-induced
PTB phosphorylation and translocation, which was previously suggested [16].
Instead, it may be that some other glucose-induced signal promoted a post-
translational modification of PTB resulting in PTB re-localization and/or altered
affinity for insulin mRNA pyrimidine rich sequences. We have not been able to
observe any glucose-induced shift in PTB position on SDS-PAGE, but many post-
translation modifications do not result in detectable alterations in gel migration. It
is also conceivable that the translation of PTB is augmented or repressed by PTB
mRNA binding miRNAs. Indeed, we have recently observed that long-term
glucotoxic conditions in human islets resulted in increased miR-133a levels and
lower PTB protein contents [44]. MiR-133a is known to inhibit nPTB translation
by binding nPTB mRNA [45], and increased miR-133a contents of human islet
cells were associated with lower insulin biosynthesis rates [44]. Additional
explanations may be that PTB becomes more actively recruited to the insulin
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mRNA via protein-protein interactions, or that PTB binding is affected by miRNA.
Indeed, it has recently been observed that miR-196b binds to the 5′-UTR of insulin
mRNA thereby displacing the RNA-binding protein HuD [46], and that this leads
to an increased biosynthesis of insulin. Therefore, it is possible that a short-term
high glucose incubation period promotes changes in miR-levels, and that this will
lead to increased PTB-insulin mRNA interaction.
It is also not clear why the binding of TIAR was modestly increased by glucose.
Hypothetically, TIAR might be released from the nucleus upon glucose
stimulation, as it is released from nuclei of other cells upon stress [47]. It is also
possible that TIAR is modified post-translationally. Nevertheless, TIAR is in most
cases associated with removal of mRNA from active translation to translational
arrest in P-bodies and stress granules [37]. It may be that a high glucose
concentration promotes both stimulatory and inhibitory signals, and that when the
cell becomes “glucose exhausted” in response to a prolonged exposure to high
glucose, the inhibitory signal predominates over the stimulatory resulting in
inhibition of insulin biosynthesis.
The putative role of PTB and other RBPs in insulin biosynthesis has, to our
knowledge, hitherto not yet been addressed. Our present findings point to a clear
correlation between insulin mRNA stability and translation, indicating that the two
processes are linked and coordinately controlled by RBP binding. Indeed, in other
cell systems it is generally agreed that active translation protects against mRNA
degradation and vice versa [37]. Binding of certain RBPs is generally associated
with translation whereas binding of another set of RBP transfers the mRNA to a
translation-inactive and degradation-active compartment [37]. The results of the
present investigation are consistent with the view that PTB increases both insulin
mRNA stability and translation, and that when other inhibitory RBPs bind, both
processes are attenuated.
The nitric oxide donor DETAnonoate, which promotes both ER- and nitrosative
stress, induced a clear increase in TIAR and hnRNP U insulin mRNA UTR
binding. Furthermore, the ER stress inducer thapsigargin evoked the formation of
TIAR-positive stress granules. The increased TIAR binding, and the concomitant
decrease in mRNA levels and translation [36], is consistent with the view that
TIAR actively participates in insulin mRNA relocalization to stress granules and p-
bodies [48]. This notion is further supported by our finding that the RNAi-
mediated decrease in TIAR resulted in an increased insulin mRNA level, stressing
that TIAR-activity is a necessary component in suppression of insulin production.
In addition, hnRNP U has been reported to participate in mRNA de-stabilization.
For example, hnRNP U is known to bind the AU-rich elements (AREs) of the
cyclooxytenase-2 mRNA [49]. These elements confer mRNA instability and low
translational rates, and hnRNP U was demonstrated to bind AREs as a multimeric
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protein complex together with HuR, TIA-1 and TIAR [49]. The exact role of
hnRNP U in the metabolism of insulin mRNA remains, however, to be clarified.
In conclusion, the insulin producing cells seem to possess a control mechanism,
which determines whether insulin mRNA is translated and inherently stable. At
stimulatory conditions PTB binding to the mRNA ensures efficient translation and
stability, but during stress, TIAR promotes mRNA removal from translation and
degradation. Further studies should inform us on how the balance between TIAR
and PTB is controlled, and whether diabetes in humans is associated with TIAR-
induced inhibition of insulin production.
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